Association of Telomere Length With Risk of Disease and Mortality

被引:89
|
作者
Schneider, Carolin, V [1 ]
Schneider, Kai Markus [2 ]
Teumer, Alexander [3 ,4 ,5 ]
Rudolph, Karl Lenhard [6 ]
Hartmann, Daniel [7 ]
Rader, Daniel J. [1 ]
Strnad, Pavel [8 ]
机构
[1] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA USA
[2] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Med Greifswald, Inst Community Med, Greifswald, Germany
[4] German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany
[5] Med Univ Bialystok, Dept Populat Med & Lifestyle Dis Prevent, Bialystok, Poland
[6] Fritz Lipmann Inst, Leibniz Inst Aging, Jena, Germany
[7] Tech Univ Munich, Sch Med, Dept Surg, Klinikum Rechts Isar, Munich, Germany
[8] Univ Hosp RWTH Aachen, Gastroenterol Metab Dis & Intens Care, Med Clin 3, Aachen, Germany
关键词
RHEUMATOID-ARTHRITIS; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; CANCER-RISK; BLOOD;
D O I
10.1001/jamainternmed.2021.7804
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Telomeres protect DNA from damage. Because they shorten with each mitotic cycle, leukocyte telomere length (LTL) serves as a mitotic clock. Reduced LTL has been associated with multiple human disorders. OBJECTIVE To determine the association between LTL and overall as well as disease-specific mortality and morbidity. DESIGN, SETTING, AND PARTICIPANTS This multicenter, community-based cohort study conducted from March 2006 to December 2010 included longitudinal follow-up (mean [SD], 12 [2] years) for 472 432 English participants from the United Kingdom Biobank (UK Biobank) and analyzed morbidity and mortality. The data were analyzed in 2021. MAIN OUTCOMES AND MEASURES Hazard ratios (HRs) and odds ratios for mortality and morbidity associated with a standard deviation change in LTL, adjusted for age, sex, body mass index (calculated as weight in kilograms divided by height in meters squared), and ethnicity. RESULTS This study included a total of 472 432 English participants, of whom 54% were women (mean age, 57 years). Reduced LTL was associated with increased overall (HR, 1.08; 95% CI, 1.07-1.09), cardiovascular (HR, 1.09; 95% CI, 1.06-1.12), respiratory (HR, 1.40; 95% CI, 1.34-1.45), digestive (HR, 1.26; 95% CI, 1.19-1.33), musculoskeletal (HR, 1.51; 95% CI, 1.35-1.92), and COVID-19 (HR, 1.15; 95% CI, 1.07-1.23) mortality, but not cancer-related mortality. A total of 214 disorders were significantly overrepresented and 37 underrepresented in participants with shorter LTL. Respiratory (11%), digestive/liver-related (14%), circulatory (18%), and musculoskeletal conditions (6%), together with infections (5%), accounted for most positive associations, whereas (benign) neoplasms and endocrinologic/metabolic disorders were the most underrepresented entities. Malignant tumors, esophageal cancer, and lymphoid and myeloid leukemia were significantly more common in participants with shorter LTL, whereas brain cancer and melanoma were less prevalent. While smoking and alcohol consumption were associated with shorter LTL, additional adjustment for both factors, as well as cognitive function/major comorbid conditions, did not significantly alter the results. CONCLUSIONS AND RELEVANCE This cohort study found that shorter LTL was associated with a small risk increase of overall mortality, but a higher risk of mortality was associated with specific organs and diseases.
引用
收藏
页码:291 / 300
页数:10
相关论文
共 50 条
  • [21] The association between telomere length and ischemic stroke risk and phenotype
    Ezgi Yetim
    Mehmet Akif Topcuoglu
    Nuket Yurur Kutlay
    Ajlan Tukun
    Kader K. Oguz
    Ethem Murat Arsava
    [J]. Scientific Reports, 11
  • [22] Association between genetic risk score for telomere length and risk of breast cancer
    Hung N. Luu
    Jirong Long
    Wanqing Wen
    Ying Zheng
    Qiuyin Cai
    Yu-Tang Gao
    Wei Zheng
    Xiao-Ou Shu
    [J]. Cancer Causes & Control, 2016, 27 : 1219 - 1228
  • [23] Leukocyte telomere length and mortality risk in patients with type 2 diabetes
    Bonfigli, Anna Rita
    Spazzafumo, Liana
    Prattichizzo, Francesco
    Bonafe, Massimiliano
    Mensa, Emanuela
    Micolucci, Luigina
    Giuliani, Angelica
    Fabbietti, Paolo
    Testa, Roberto
    Boemi, Massimo
    Lattanzio, Fabrizia
    Olivieri, Fabiola
    [J]. ONCOTARGET, 2016, 7 (32) : 50835 - 50844
  • [24] Association between genetic risk score for telomere length and risk of breast cancer
    Luu, Hung N.
    Long, Jirong
    Wen, Wanqing
    Zheng, Ying
    Cai, Qiuyin
    Gao, Yu-Tang
    Zheng, Wei
    Shu, Xiao-Ou
    [J]. CANCER CAUSES & CONTROL, 2016, 27 (10) : 1219 - 1228
  • [25] Leukocyte Telomere Length and Cardiovascular Risk Scores for Prediction of Cardiovascular Mortality
    Barger, Steven D.
    Cribbet, Matthew R.
    Muldoon, Matthew F.
    [J]. EPIDEMIOLOGY, 2017, 28 (02) : E13 - E15
  • [26] The association of mean telomere length with all-cause, cerebrovascular and cardiovascular mortality
    Huang, Yu-qing
    Lo, Kenneth
    Feng, Ying-qing
    Zhang, Bin
    [J]. BIOSCIENCE REPORTS, 2019, 39
  • [27] Association of adiposity, telomere length and mortality: data from the NHANES 1999–2002
    J A Batsis
    T A Mackenzie
    E Vasquez
    C M Germain
    R T Emeny
    P Rippberger
    F Lopez-Jimenez
    S J Bartels
    [J]. International Journal of Obesity, 2018, 42 : 198 - 204
  • [28] The association of sarcopenia, telomere length, and mortality: data from the NHANES 1999–2002
    Peter L. Rippberger
    Rebecca T. Emeny
    Todd A. Mackenzie
    Stephen J. Bartels
    John A. Batsis
    [J]. European Journal of Clinical Nutrition, 2018, 72 : 255 - 263
  • [29] Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study
    Fani, Lana
    Hilal, Saima
    Sedaghat, Sanaz
    Broer, Linda
    Licher, Silvan
    Arp, Pascal P.
    van Meurs, Joyce B. J.
    Ikram, M. Kamran
    Ikram, M. Arfan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (02) : 707 - 714
  • [30] The association between leukocyte telomere length, telomere attrition and disease severity in cystic fibrosis patients
    Lammertyn, Elise
    Martens, Dries
    Colpaert, Kristine
    Goeminne, Pieter
    Proesmans, Marijke
    Vanaudenaerde, Bart
    Nawrot, Tim
    Dupont, Lieven
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50